Gregory Kulessa

Gregory Kulessa is a seasoned professional in the pharmaceutical industry with extensive experience in commercial analytics and strategic business development. Currently serving as Senior Director of Commercial Analytics at Intra-Cellular Therapies since March 2023, Gregory previously held various leadership roles at The Janssen Pharmaceutical Companies of Johnson & Johnson from 2010 to August 2023, including Director of Business Development & Portfolio Strategy for Neuroscience and Director of Analytics for Immunology. Gregory's expertise encompasses market assessment for psychiatric and neurological diseases, analysis to drive the success of new product launches, and strategic insights for growth in various therapeutic areas. Earlier roles include Senior Manager in Oncology analytics at Janssen Inc. and Manager of Global Market Insights at Bristol-Myers Squibb for the Cardiovascular and Metabolic Division. Gregory holds an MBA in Marketing from Cornell Johnson Graduate School of Management and a BA in Economics and Psychology from Harvard University.